Zoetis Inc. ZTS
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · zoetis.com
Zoetis Inc. is a global animal health company engaged in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, and precision health solutions for livestock and companion animals worldwide. The company serves veterinarians, livestock producers, and pet owners with products spanning parasiticides, vaccines, anti-infectives, dermatology treatments, and diagnostics.
Key ratios
FreeCashFlowOnSale TTM 0.24
FreeCashFlowOnSale 2025 0.24
FreeCashFlowOnSale 2024 0.25
FreeCashFlowOnSale 2023 0.19
NetIncomeMargin TTM 0.28
NetIncomeMargin 2025 0.28
NetIncomeMargin 2024 0.27
NetIncomeMargin 2023 0.27
ReturnOnAssets TTM 0.15
ReturnOnAssets 2025 0.15
ReturnOnAssets 2024 0.15
ReturnOnAssets 2023 0.13
ReturnOnEquity TTM 0.66
ReturnOnEquity 2025 0.66
ReturnOnEquity 2024 0.51
ReturnOnEquity 2023 0.5
Recent news
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
2026-06-26 · PR Newswire
Zoetis Announces First Quarter 2026 Results
2026-05-07 · Zoetis Investor Relations
Zoetis Declares Second Quarter 2026 Dividend
2026-02-05 · Zoetis Investor Relations